Visteon (VC) CEO sells 49,826 shares in pre-set 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Visteon Corp CEO and President Sachin Lawande reported a mix of stock option exercises and share sales in Visteon common stock. On April 23–24, he exercised options to acquire 49,826 shares at a strike price of $66.98 per share and sold 49,826 shares in open-market transactions at prices generally around the low-to-mid $110s.
The filing notes these trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 31, 2025, indicating they were scheduled in advance. Following the reported transactions, Lawande directly owns 231,339 shares of Visteon common stock.
Positive
- None.
Negative
- None.
Insights
Visteon’s CEO executed a pre-planned exercise-and-sell of options, with sizeable stock holdings remaining.
CEO and President Sachin Lawande exercised options for 49,826 Visteon shares at a strike price of $66.98 and sold an equal number of shares between roughly $110 and $115.27 per share. These are classic exercise-and-sell transactions that convert an existing option position into cash and common shares.
The filing states the trades were carried out under a Rule 10b5-1 trading plan adopted on July 31, 2025, suggesting they were scheduled rather than opportunistic. After the transactions, Lawande still directly holds 231,339 common shares, indicating he retains a substantial equity stake. Overall, this looks like routine liquidity and compensation management rather than a thesis-changing move.
Insider Trade Summary 10b5-1
Net Seller: 49,826 shares ($5,622,695)
Net Sell
10 txns
Insider
Lawande Sachin
Role
CEO and President
Sold
49,826 shs ($5.62M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 38,817 | $0.00 | -- |
| Exercise | Common Stock | 38,817 | $66.98 | $2.60M |
| Sale | Common Stock | 1,300 | $110.81 | $144K |
| Sale | Common Stock | 4,850 | $112.64 | $546K |
| Sale | Common Stock | 19,822 | $113.52 | $2.25M |
| Sale | Common Stock | 12,045 | $114.40 | $1.38M |
| Sale | Common Stock | 800 | $115.27 | $92K |
| Exercise | Employee Stock Option (right to buy) | 11,009 | $0.00 | -- |
| Exercise | Common Stock | 11,009 | $66.98 | $737K |
| Sale | Common Stock | 11,009 | $110.09 | $1.21M |
Holdings After Transaction:
Employee Stock Option (right to buy) — 0 shares (Direct, null);
Common Stock — 232,639 shares (Direct, null)
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2025 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 - $110.27, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.57 - $110.83, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 - $112.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.03 - $114.02, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.03 - $115.02, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.16 - $115.50, inclusive. The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.
Key Figures
Shares sold: 49,826 shares
Shares exercised: 49,826 shares
Option strike price: $66.98 per share
+4 more
7 metrics
Shares sold
49,826 shares
Total open-market sales reported in this Form 4
Shares exercised
49,826 shares
Total options exercised (M code) for common stock
Option strike price
$66.98 per share
Employee stock option exercise price for common stock
Sale prices range
$110.00–$115.50 per share
Weighted average price ranges in footnote-disclosed trades
Post-transaction holdings
231,339 shares
Common shares directly owned after reported transactions
Net buy/sell direction
net-sell of 49,826 shares
From transaction summary netBuySellShares field
Trading plan adoption date
July 31, 2025
Date Rule 10b5-1 trading plan was adopted
Key Terms
Rule 10b5-1 trading plan, weighted average price, Employee Stock Option (right to buy), derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Option (right to buy) financial
"security_title: "Employee Stock Option (right to buy)""
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What did Visteon (VC) CEO Sachin Lawande report in this Form 4 filing?
Sachin Lawande reported exercising stock options and selling Visteon common shares. He exercised 49,826 options at a strike price of $66.98 and sold 49,826 shares in open-market trades at prices generally in the low-to-mid $110s per share.
Did Visteon (VC) CEO’s transactions involve stock option exercises?
Yes. Sachin Lawande exercised employee stock options covering 49,826 shares of Visteon common stock at a strike price of $66.98 per share. These exercises converted a derivative position into common shares, which were then paired with open-market sales of an equal number of shares.
What is the net effect of the Visteon (VC) CEO’s Form 4 activity?
The filing shows a net sale of 49,826 shares, matched to exercises of 49,826 options. According to the summarized data, this resulted in “net-sell” activity, while still leaving the CEO with a sizeable remaining direct ownership stake in Visteon common stock.